7th World Congress on Hypertension and Public Health

About the Conference

Euro Hypertension 2019 proudly announces the "7th World Congress on Hypertension and Public Health" which will be held during September 26-28, 2019 at Lisbon, Portugal, after the brand success of “World Congress on Hypertension and Cardiovascular Diseases”.
Euro Hypertension 2019 will lay a platform for all the scientists, world-class professors, and cardiologists, nephrologist, endocrinologist, psychiatrists, osteopathicians , bariatric,  nurses, healthcare professionals to discuss an approach for hypertension and diagnosis, treatment and prevention of elevated blood pressure.
Hypertension is fairly common among the human population and is oft en unregulated; however, uncontrolled increase in blood pressure leaves the individuals at risk to develop heart ailments. According to a report by the World Health Organization in 2018, 1.1 billion people in the world have a raised blood pressure and less than 1 in 5 have it under control. Treatment of cardiovascular disease often requires the administration of numerous medications for long periods of time to patients likely to be old and suffering from a range of co-morbid conditions. This Conference is dedicated to incite discussions that promote innovations and fresh perspectives to the existing research related to cardiovascular diseases and hypertension.

Market Analysis

According to Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is reckoned for $23,849.39 Million in 2017 and is estimated to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period.
Factors like technological advancement, a growing aging population, and people affected by diabetes, high blood pressure are favouring the market. On the other hand, increasing health expenditure, cardiovascular diseases and increasing tobacco users are supplying the market.
Hypertension is a chronic medical condition during which the blood pressure is elevated to an unsought level. Hypertension is a chronic disease, which means that a patient could need to require medications a day for the rest of his/her life. Thus, the demand for anti-hypertensive medication is property and can increase with a rise within the variety of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the worldwide sales worth of over USD 40 billion, according to the globe Preview 2018 report by valuate drug company.
Some of the key players contributing to the worldwide anti-hypertensive medication market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, and Takeda Pharmaceutical Company Limited.
This research report analyses this market counting on its market segments, major geographies, and current market trends. Geographies analysed under this analysis report include
• North America
• Asia Pacific
• Europe
• Rest of the World 

Why Attend?

Hypertension meet 2019 is a distinctive forum to assemble worldwide distinguished academics within the field of cardiology, nephropathy, neuropathy, endocrinology, psychiatry , public health professionals, scientists, educational scientists, industry researchers, scholars to exchange concerning state of the art analysis and provides the best chance to reach the biggest gathering of participants from round the world. Conduct displays, distribute and update information concerning the current state of affairs of hypertension treatment and their effects that leads to the downfall of the society. This 2-day event can surely profit and paves the way for the betterment of the globe. Broadly acclaimed speakers, the foremost recent researches and updates in hypertension are the key features of this event.
The benefits provided to the attendees are:
  • CME accreditation certificates will be provided to all speakers, delegates and students
  • Opportunity to meet world’s renowned at this CME event
  • Keynote forums by Prominent Physicians & Professors
  • Best platform for Global business and networking opportunities
  • Oral/Poster presentations by Young Researchers
  • Best poster award for students

Sessions / Tracks of the conference

 Track 1:  Hypertension
Hypertension is the systemic condition accompanying high blood pressure. This remains as one of the common medical problems. High blood pressure is a common condition in which the long-term force of the blood against the artery walls is high enough that it may eventually cause health problems, such as heart failurechronic kidney diseasecoronary artery diseasestrokeatrial fibrillation, vision loss, peripheral vascular disease and dementia. There are two types of high blood pressure, such as primary (essential) hypertension, it tends to develop gradually over many years whereas secondary hypertension tends to develop gradually over many years. People with high blood pressure may have symptoms of headache, shortness of breath, nosebleeds, dizziness, chest pain, visual changes, blood in the urine.
The risk factors of high blood pressure includes age, race, obesity, Family history, use of tobacco, high intake of salt and lower intake of potassium, stress and certain chronic conditions.

Pulmonary hypertension (PH) is high blood pressure in the arteries to the lungs where the blood vessels that carry blood from the heart to the lungs become hard and narrow, this causes difficulty in pumping the blood, which ultimately weakens the heart leading to the condition of heart failure. However, recent advances in drug therapy have created major impact in the developments of symptom management and survival. The PH symptoms are dizziness, chest pain, swelling in the ankles, legs and abdomen, bluish colour in lips and skin, racing pulse or heart palpitations. PH may be the result of diseases in the pulmonary arteries, left heart failurelung diseasepulmonary embolism.
High blood pressure in children and adolescents is one of the most common problems that the children are facing. They may contribute to premature atherosclerosis and the early development of cardiovascular diseasesPediatric hypertension can be either primary or secondary and they are categorized as prehypertension (between 90th to 95th percentile), stage 1 (95th to 99th percentile plus 5 mmHg) and stage 2 (≥ 99th percentile plus 5 mmHg) hypertension. People who are between 3 to 18 years of age, the prevalence of prehypertension and hypertension was found to be 3.4 % and 3.6 % respectively.  Normally a blood pressure values varies by age, sex, and height. Therefore, awareness has to be taken seriously for the diagnosis and treatment of hypertension.
Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of high blood pressure greater than 140/90 mm Hg in a pregnant woman. It occurs after 20 weeks of gestation and leads to a serious condition called preeclampsia, also referred to as toxemia. Due to this condition, it may prevent the placenta from receiving enough blood, which can cause low birth weight in the baby.
The symptoms of gestational hypertension includes rapid weight gain, high blood pressure, protein in the urine, and swelling in the hands, feet, and face, severe headaches, a change in reflexes, reduced output of urine or no urine, abdominal pain, blood in the urine, dizziness, or excessive vomiting and nausea, spots before the eyes.
•           Chronic Hypertension
•           Gestational Hypertension
•           Preeclampsia

Resistant hypertension is defined as uncontrolled blood pressure elevating to approximately (>140/90 mm Hg) after treatment with three or more antihypertensive drugs, such patients are more likely to have a secondary cause and has a high risk of end-organ damage. ACE inhibitor (or an angiotensin receptor blocker), a diuretic and a calcium channel blocker preclude resistant hypertension, which must be ruled out before a diagnosis can be made.
The prognosis of resistant hypertension is not known, however cardiovascular risk is beyond any doubt raised as patients usually have a history of long-standing, severe hypertension sophisticated by multiple different cardiovascular risk factors such as obesity, sleep apnea, diabetes, and chronic renal disorder. The diagnosing of resistant hypertension needs use of excellent blood pressure technique to verify persistently elevated blood pressure levels. Pseudo resistance, including lack of blood pressure management secondary to poor medication adherence or white coat hypertension, should be excluded.
Sexual dysfunction is difficulty experienced by an individual during any stage of sexual activity, including physical pleasure, desire, arousal or orgasm. The common risk factors associated with sexual dysfunction for men and women including individual general health status, cardiovascular disease, other genitourinary disease, psychiatric/psychological disorders, diabetes mellitus, other chronic disease, and socio-demographic conditions.
During the treatment of hypertension, antihypertensive drugs such as diuretics, potassium sparring diuretics and β-blockers are used, which results in erectile dysfunction. Sexual dysfunction disorders may be classified into four types: orgasm disorders, sexual desire disorders, arousal disorders and pain disorders.
Hypertension is an extremely common comorbid condition in diabetes which significantly reduces the risk of macrovascular and microvascular complications, including strokecoronary artery disease, and peripheral vascular disease, retinopathy, nephropathy, and possibly neuropathy.  It majorly depends on obesity, age and ethnicity. The use of angiotensin-converting enzyme inhibitors may slow progression to kidney failure and cardiovascular mortality, but these agents are the preferred therapy for managing diabetes and hypertension.

Renal hypertension or renovascular hypertension is elevated blood pressure due to narrowing of the arteries that carry blood to the kidneys or the blockage in the arteries due to high cholesterol. This condition is also called renal artery stenosis. As a consequence of this condition the kidney organs release hormones to maintain a higher amount of sodium and water, which in turn causes blood pressure to rise. It is usually controlled by antihypertensive drugs or treatments like stenting, angioplasty and surgery on the blood vessels of the kidney.

Hypertensive heart disease refers to heart problems occurring due to elevated blood pressure that is present over an extended period of time. Without treatment of high blood pressure, symptoms of heart failure can develop. It may lead to the thickening of the muscles which ultimately results in the deficient of the oxygen, this may cause angina(chest pain). High blood pressure also ends up in thickening of the blood vessel walls. When combined with cholesterol deposits within the blood vessels, the chance of heart attack and stroke will increase. Hypertensive heart disease is that the leading cause of unwellness and death from high blood pressure.

Hypertension is the single most important risk factor for stroke, doubling the risk of stroke for each 20 mm Hg increase in systolic blood pressure (SBP). Although reducing the blood pressure can lower stroke risk by 30% to 40%
In comparison with other antihypertensive agents, angiotensin receptor blockers (ARB) provide additional protection against stroke and other cardiovascular diseases.
The strain hypertension weakens the blood vessels and predisposes them to damage, results in the blockage. This causes an ischemic stroke and hypertension is the most important cause of this type of stroke and also transient ischemic attacks.

Obesity increases the risk of the development of hypertension. Obesity-associated arterial hypertension is characterized by stimulation of the sympathetic nervous system, reaction of the renin-angiotensin system, and sodium retention, among other abnormalities. Obesity is characterized with increased blood flow, vasodilatation, cardiac output, and hypertension. Although cardiac index does not increase, cardiac output and glomerular filtration rate do. However, renal sodium retention also increases, leading to the cause of hypertension.

The risk factors of hypertension are age, smoking, diet, alcohol, cholesterol level, diabetes, ethnicity, family history, obesity, sedentary lifestyle, medication, recreation drugs. Regular physical activity decreases the risk of cardiovascular disease including high blood pressure, diabetes, breast and colon cancer, and depression. The prevention of hypertension is possible based on correct lifestyle and nutrition, starting from childhood age. The mediation that are used to treat high blood pressure are Thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockersalpha blockersalpha-beta blockersbeta blockers, aldosterone antagonists, renin inhibitors,  vasodilators, central-acting agents.

 In 1991, the National High Blood Pressure Education Program (NHBPEP) estimated that in United States, 43.3 million adults had hypertension. Overall, approximately 20% of the world’s adults are estimated to have high blood pressure. The prevalence dramatically elevates in patients older than 60 years: In many countries, 50% of individuals in this age group have hypertension. Worldwide, approximately 1 billion people have hypertension, contributing to more than 7.1 million deaths per year.
National health surveys in various countries have shown a high prevalence of poor control of hypertension. [6] These studies have reported that prevalence of hypertension is 22% in Canada, of which 16% is controlled; it is 26.3% in Egypt, of which 8% is controlled; and it is 13.6% in China, of which 3% is controlled.

Track 14: Cardiology
Cardiology is a branch of medicine dealing with disorders of the heart and also the parts of the circulatory system. The field includes medical diagnosis and treatment of coronary artery disease, heart failure, congenital heart defects, valvular heart disease and electrophysiology. The symptoms that indicates a heart problem includes, shortness of breath, changes in heart rate or rhythm, high blood pressure, dizziness, chest pains.

The term global means international. Thus Global mental health defines the international viewpoint on various aspects of mental health. Its overall aim is to strengthen mental health all over the world by providing information about the mental health conditions in all countries, and classifying mental health care requirements in order to develop economical interventions to fulfil those specific requirements. Global mental health puts priority on improving mental health and achieving fairness in mental health for all individuals worldwide by study, research and practice. Lately, the global mental health movement has met with some criticism. It has been labelled as a cover for the pharmaceutical companies searching for new consumers for psychiatric drugs. Mental disorders are considered as health conditions categorized by changes in state of mind, mood and behaviour that are associated with pain or potentially disability in working. Mental illness refers to all diagnosable mental disorders. Mental disorders are one of the most well-known causes for disability and may incorporate death in some cases. Approximately, one in four people in the world is somehow affected by mental or neurological disorder at some point in their lives. Although there is rise in interventions for treatment of mental disorders and awareness about mental disorders among people, the so called treatment gap is still very high. The treatment gap is estimated to be in between 76–85% for low- and middle-income countries and 35–50% for high-income countries.

Abstract Submission Criteria & Eligibility

Presenting authors are responsible for registration, hotel costs and travel.
Note: The accepted abstracts will receive an acceptance letter in the mail allowing them to register for the conference.
Abstracts will be compiled and conference books are made available to participants at the conference days.
Any presenter who is unable to attend should arrange for another qualified individual to present the paper in place of the speaker. If such a change is necessary, please notify the program manager
Bincy Matthews
Contact information:


Oral paper presentations will have 25-30 minute time slot and be clustered by topic into sessions. The keynote session will have for 45-minute time slot, workshop/ special session will have 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute question and answer session.
Graduate & Masters students are eligible to submit their abstracts under poster or oral.
Special certificates will be given to the Student ambassador, Moderators and Best poster award.
Ph.D. students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and oral presentation category.
NOTE: YRF category includes short oral presentation; this offer is subjected mainly for Ph. D. students
Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, critiques or reviews.
Note: Affiliation, Photograph should be attached along with the abstract.
Visa and Embassy
Planning a Trip to Paris?? Attend our Meeting!!!
An issue with VISA!!
Euro Hypertension 2019 Committee will be glad to help you in all regards to plan your trip to Lisbon, Portugal.  Get the official invitation letter from us by paying the token amount of $100 to attend this event and ahead with a closer step for approval of your VISA

City Attractions of Lisbon:
·         Castelo de São Jorge: An Iconic Landmark
·        Mosteiro dos Jerónimos: Built in Honor of Portugal's Age of Discovery
·         Oceanário de Lisboa: A Modern Aquarium
·         Museu Calouste Gulbenkian: A Priceless Collection of Western and Eastern Art
·         Museu Nacional de Arte Antiga:The National Museum of Ancient Art
·         Museu do Oriente: Showcasing Portugal's Presence in Asia and the Far East
·         Torre de Belém: A Historic Tower
·         Museu Nacional do Azulejo: Dedicated to the art of Decorative Tilework
·        Elevador de Santa Justa: An Antique Elevator With City Views
·         Sé: Lisbon's Imposing Cathedral
·         Padrão dos Descobrimentos: A Tribute to the Age of Discovery
·         Day Trip to Sintra
·         Arco da Rua Augusta: A Triumphal Arch
·         Lisboa Story Centre: Exploring Lisbon's Vibrant History
·         Igreja do Carmo: One of the City's Oldest Churches
·         Igreja-Museu São Roque: A Simple Church With a Richly Decorated Interior
·         Núcleo Arqueológico: An Incredible Journey Through Hidden Lisbon
·         Museu Bordalo Pinheiro
·         Palácio dos Marqueses de Fronteira: The Home of a 17th-Century Portuguese Aristocrat
·         Aqueduto das Águas Livres / Mãe d'Agua das Amoreiras
·         Basílica da Estrela: The Beautiful Star Basilica and many more...
NOTE: A Letter of Invitation is proof that your paper submission and registration application are accepted by the conference committee board. The invitation letter will be provided after the attendee confirms his/her participation by reserving their delegate/ speaker slot for the conference.
Invitation letters will be sent by e-mail.
In order to request an invitation letter, just e-mail us with the following data:
·         Registration Form
·         Payment Proof
·         Passport Scan Copy
For the individuals who require a visa, it would be ideal if you know that Euro Hypertension 2019 Sorting out Board has no power over the visa application process or the choice of the visa adjudicator in the government office. If your application be denied, we can't change the choice of the Service of Remote Undertakings, nor will we take part in dialog or correspondence with the Ministry of Foreign Affairs (MOFA) or the International safe haven for the benefit of the candidate.


Popular posts from this blog

6th World Congress on Hypertension and Public Health